Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
Inactive · Last trade price on Aug 20, 2025
Accelerate Diagnostics Revenue
In the year 2024, Accelerate Diagnostics had annual revenue of $11.70M, down -2.99%. Accelerate Diagnostics had revenue of $2.82M in the quarter ending December 31, 2024, a decrease of -6.97%.
Revenue
11.70M
Revenue Growth
-2.99%
P/S Ratio
n/a
Revenue / Employee
109.33K
Employees
107
Market Cap
25.00
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.70M | -361.00K | -2.99% |
| Dec 31, 2023 | 12.06M | -693.00K | -5.43% |
| Dec 31, 2022 | 12.75M | 970.00K | 8.23% |
| Dec 31, 2021 | 11.78M | 617.00K | 5.53% |
| Dec 31, 2020 | 11.17M | 1.87M | 20.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Accelerate Diagnostics News
- 1 year ago - Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - PRNewsWire
- 1 year ago - Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PRNewsWire
- 1 year ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 1 year ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 1 year ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 1 year ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 2 years ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire
- 2 years ago - Accelerate Diagnostics Reports Second Quarter 2024 Financial Results - PRNewsWire